References
- Lawson I. R., MacLeod R. D. The use of Imipramine and other psychotropic drugs in organic emotionalism. British Journal of Psychiatry 1969; 115: 281–285
- House A., Dennis M., Molyneux A., et al. Emotionalism after stroke. British Medical Journal 1989; 298: 991–994
- Schiffer R. D., Herndon R., Rudick R. Treatment of pathologic laughing and weeping with amitnptyline. New England Journal of Medicine 1985; 312: 1480–1482
- Udaka F., Yamao S., Nagata H., et al. Pathologic laughing and crying treated with levodopa. Archives of Neurology 1984; 41: 1095–1096
- Wolf J. K., Santana H. G., Thorpy M. Treatment of emotional incontinence' with levodopa. Neurology 1979; 29: 1435–1436
- Lader M., Petursson H. Psychiatric disorders. Textbook of Medical Treatment. 15th edn., R. H. Girdwood, J. Petrie. Churchill Livingstone, Edinburgh 1987; 285–302
- Poeck K. Pathophysiology of emotional disorders associated with brain damage. Handbook of Clinical Neurology, P J. Vinken, G. W. Bruyn. Elsevier, New York 1969; 343–367
- Ross E. D., Stewart R. S. Pathological display of affect in patients with depression and right frontal brain damage. Journal of Nervous and Mental Disease 1987; 175: 165–172
- Lemberger L., Rowe H., Carmichael R., et al. Fluoxetine, a selective serotonin uptake inhibitor. Clinical Pharmacology and Therapeutics 1978; 23: 421–429
- Wong D. T., Bymaster F. P., Reid L. R., et al. Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors. Biochemical Pharmacology 1983; 32: 1287–1293
- Benfield P., Heel R. C., Lewis S. P. Fluoxetine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in depressive illness. Drugs 1986; 32: 481–508